Vergin H, Bishop-Freudling G B, Foing N, Szelenyi I, Armengaud H, van Tho T
Chemotherapy. 1984;30(5):297-304. doi: 10.1159/000238284.
The diffusion of metioprim (MTP), tetroxoprim (TXP) and sulphadiazine (SDZ) in cerebrospinal fluid (CSF), following single intravenous doses and continuous infusions, was studied in dogs. The drugs penetrated well into the CSF of animals with and without experimental Staphylococcus aureus meningitis. In dogs with healthy meninges, the CSF bioavailability - expressed as the ratio of CSF/plasma area under the curve 0-5-hour values - following continuous infusion was determined to be 86.7% for MTP, 58.2% for TXP and 38.8% for SDZ. In infected animals, CSF availability following continuous infusion increases slightly to ratios of 96% (MTP), 70% (TXP) and 50% (SDZ). For all drugs, the concentrations reached in CSF were above the minimum inhibition concentrations for the majority of Enterobacteriaceae, indicating their potential value in treatment of gram-negative bacillary meningitis.
在犬类动物中,研究了单剂量静脉注射和持续输注后,甲硫普林(MTP)、甲氧苄氨嘧啶(TXP)和磺胺嘧啶(SDZ)在脑脊液(CSF)中的扩散情况。这些药物在患有和未患有实验性金黄色葡萄球菌脑膜炎的动物脑脊液中均能良好渗透。在脑膜健康的犬类中,持续输注后,脑脊液生物利用度(以0至5小时曲线下脑脊液/血浆面积比值表示),甲硫普林为86.7%,甲氧苄氨嘧啶为58.2%,磺胺嘧啶为38.8%。在受感染动物中,持续输注后脑脊液利用率略有增加,甲硫普林、甲氧苄氨嘧啶和磺胺嘧啶的比值分别为96%、70%和50%。对于所有药物,脑脊液中达到的浓度高于大多数肠杆菌科细菌的最低抑菌浓度,表明它们在治疗革兰氏阴性杆菌性脑膜炎方面具有潜在价值。